Evidence map›Paper›PMID 28514723›Full record

ArticleCold Spring Harbor molecular case studies2017

Genomic profiling of pelvic genital type leiomyosarcoma in a woman with a germline

My Linh Thibodeau, Caralyn Reisle, Eric Zhao, Lee Ann Martin, Yazeed Alwelaie, Karen L Mungall, Carolyn Ch'ng, Ruth Thomas, Tony Ng, Stephen Yip and 15 more

Erratum issuedOpen access · diamondAbstract readCase Reports
In one paragraph

Article in Cold Spring Harbor molecular case studies, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. CD34-positive pleomorphic uterine sarcoma with NUDT3::RAD51B fusion.Virchows Archiv : an international journal of pathology · 2025
    Article
  4. Sarcomas With RAD51B Fusions Are Associated With a Heterogeneous Phenotype.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors at 3 institutions in 1 country.

My Linh ThibodeauDepartment of Medical Genetics, University of British Columbia, Vancouver, British Columbia V6H 3N1, Canada.ORCID http://orcid.org/0000-0002-2600-1197
Caralyn ReisleCanada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, British Columbia V5Z 4S6, Canada.
Eric ZhaoCanada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, British Columbia V5Z 4S6, Canada.ORCID http://orcid.org/0000-0003-1277-6335
Lee Ann MartinFraser Valley Cancer Centre, British Columbia Cancer Agency, Surrey, British Columbia V3V 1Z2, Canada.
Yazeed AlwelaieDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V5Z 1M9, Canada.
Karen L MungallCanada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, British Columbia V5Z 4S6, Canada.
Carolyn Ch'ngCanada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, British Columbia V5Z 4S6, Canada.
Ruth ThomasHereditary Cancer Program, British Columbia Cancer Agency-Abbotsford, Abbotsford, British Columbia V2S 0C2, Canada.
Tony NgDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V5Z 1M9, Canada.
Stephen YipDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V5Z 1M9, Canada.
Howard J LimBritish Columbia Cancer Agency, Vancouver, British Columbia V5Z 4E6, Canada.
Sophie SunBritish Columbia Cancer Agency, Vancouver, British Columbia V5Z 4E6, Canada.
Sean S YoungDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V5Z 1M9, Canada.
Aly KarsanCanada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, British Columbia V5Z 4S6, Canada.
Yongjun ZhaoCanada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, British Columbia V5Z 4S6, Canada.
Andrew J MungallCanada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, British Columbia V5Z 4S6, Canada.
Richard A MooreCanada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, British Columbia V5Z 4S6, Canada.
Daniel J RenoufBritish Columbia Cancer Agency, Vancouver, British Columbia V5Z 4E6, Canada.
Karen GelmonBritish Columbia Cancer Agency, Vancouver, British Columbia V5Z 4E6, Canada.
Yussanne P MaCanada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, British Columbia V5Z 4S6, Canada.
Malcolm HayesDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V5Z 1M9, Canada.
Janessa LaskinDepartment of Medical Genetics, University of British Columbia, Vancouver, British Columbia V6H 3N1, Canada.
Marco A MarraDepartment of Medical Genetics, University of British Columbia, Vancouver, British Columbia V6H 3N1, Canada.
Kasmintan A SchraderHereditary Cancer Program, Department of Medical Genetics, British Columbia Cancer Agency, 614-750 West Broadway, Vancouver British Columbia V5Z 1H5, Canada.
Steven J M JonesDepartment of Medical Genetics, University of British Columbia, Vancouver, British Columbia V6H 3N1, Canada.
BC Cancer Agency · CACanada's Michael Smith Genome Sciences Centre · CAUniversity of British Columbia · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We describe a woman with the known pathogenic germline variant

Indexed as

AllelesBreast NeoplasmsCarcinoma, Ductal, BreastCheckpoint Kinase 2DNA-Binding ProteinsDNA RepairFemaleGenetic Predisposition to DiseaseGenomicsGerm-Line MutationHMGA2 ProteinHumansLeiomyosarcomaMiddle AgedMutationNeoplasm MetastasisCheckpoint Kinase 2CHEK2 protein, humanDNA-Binding ProteinsHMGA2 ProteinRAD51B protein, humanneoplasm of the breastuterine leiomyosarcoma

Identifiers

PMID28514723
PMCPMC5593158
OpenAlexW2616131888

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.